PreprintCited by 625CRISPR and Genetic EngineeringRNA regulation and diseaseRNA Interference and Gene Delivery

Sequence determinants of improved CRISPR sgRNA design

Open access
Xu, Han, Xiao, Tengfei, Chen, Chen-Hao, Li, Wei, Meyer, Clifford A., Wu, Qiu, Wu, Di, Cong, Le +4 more·2015·Genome Research

Abstract

The CRISPR/Cas9 system has revolutionized mammalian somatic cell genetics. Genome-wide functional screens using CRISPR/Cas9-mediated knockout or dCas9 fusion-mediated inhibition/activation (CRISPRi/a) are powerful techniques for discovering phenotype-associated gene function. We systematically assessed the DNA sequence features that contribute to single guide RNA (sgRNA) efficiency in CRISPR-based screens. Leveraging the information from multiple designs, we derived a new sequence model for predicting sgRNA efficiency in CRISPR/Cas9 knockout experiments. Our model confirmed known features and suggested new features including a preference for cytosine at the cleavage site. The model was experimentally validated for sgRNA-mediated mutation rate and protein knockout efficiency. Tested on independent data sets, the model achieved significant results in both positive and negative selection conditions and outperformed existing models. We also found that the sequence preference for CRISPRi/a is substantially different from that for CRISPR/Cas9 knockout and propose a new model for predicting sgRNA efficiency in CRISPRi/a experiments. These results facilitate the genome-wide design of improved sgRNA for both knockout and CRISPRi/a studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gr.191452.115

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Key sequence information previously obtained in SpCas9-WT was further verified in several variants in this study, such as the preference of G base in the gRNA spacer, including the preference of G bases in the PAM-distal region.

    “Some of the key sequence information previously obtained in SpCas9-WT was further verified in several variants in our study, such as the preference of G base in the gRNA spacer, including the preference of G bases in the PAM-distal region.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xu, H., Xiao, T., Chen, C.-H., Li, W., Meyer, C. A., Wu, Q., Wu, D., Cong, L., Zhang, F., Liu, J. S., Brown, M., & Liu, X. S.
Affiliations
  • Harvard University (US)
  • Tongji University (CN)
  • Broad Institute (US)
  • Brigham and Women's Hospital (US)
Venue
Genome Research
Published
2015-06-10
Volume
25
Issue
8
Pages
1147-1157
ISSN
  • 1088-9051 (ISSN-L)
  • 1549-5469
OpenAlex
W1879165674
Cited by
625
References
29
Citations by year
2026: 20 · 2025: 47 · 2024: 59 · 2023: 60 · 2022: 72 · 2021: 77 · 2020: 72 · 2019: 60 · 2018: 47 · 2017: 53 · 2016: 41 · 2015: 16 · 2013: 1
Type
posted content
Language
en
Open access
Locations
  • Genome Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Funders
  • National Institute for Health Research (U01 CA180980, R01 GM113242-01)
  • National Science Foundation (DMS-1120368)
  • Dana-Farber Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
CRISPR/Cas9, single guide RNA design, sequence determinants, knockout efficiency, mutation rate, positive and negative selection
MeSH terms
RNA, Guide, CRISPR-Cas Systems, DNA, Humans, Models, Genetic, HL-60 Cells, Computational Biology, Gene Knockout Techniques, Mutation Rate, Clustered Regularly Interspaced Short Palindromic Repeats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review